换一批Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
第一作者：
Maximilian,Stahl
第一单位：
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
作者：
Maximilian,Stahl [1]
;
Andriy,Derkach [2]
;
Noushin,Farnoud [3]
;
Jan Philipp,Bewersdorf [4]
;
Troy,Robinson [5]
;
Christopher,Famulare [6]
;
Christina,Cho [7]
;
Sean,Devlin [2]
;
Kamal,Menghrajani [8]
;
Minal A,Patel [6]
;
Sheng F,Cai [9]
;
Linde A,Miles [10]
;
Robert L,Bowman [10]
;
Mark B,Geyer [11]
;
Andrew,Dunbar [12]
;
Zachary D,Epstein-Peterson [13]
;
Erin,McGovern [6]
;
Jessica,Schulman [6]
;
Jacob L,Glass [8]
;
Justin,Taylor [14]
;
Aaron D,Viny [15]
;
Eytan M,Stein [8]
;
Bartlomiej,Getta [8]
;
Maria E,Arcila [16]
;
Qi,Gao [17]
;
Juliet,Barker [7]
;
Brian C,Shaffer [7]
;
Esperanza B,Papadopoulos [7]
;
Boglarka,Gyurkocza [7]
;
Miguel-Angel,Perales [7]
;
Omar,Abdel-Wahab [18]
;
Ross L,Levine [19]
;
Sergio A,Giralt [7]
;
Yanming,Zhang [17]
;
Wenbin,Xiao [17]
;
Nidhi,Pai [20]
;
Elli,Papaemmanuil [21]
;
Martin S,Tallman [22]
;
Mikhail,Roshal [17]
;
Aaron D,Goldberg [8]
作者单位：
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
[1]
Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
[2]
Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[3]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[4]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, New York, USA.
[5]
Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[6]
Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.
[7]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.
[8]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.;Center for Epigenetic Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[9]
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[10]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.;Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[11]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.
[12]
Weill Cornell Medical College, New York, New York, USA.;Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[13]
Sylvester Comprehensive Cancer Center at the University of Miami, Miami, Florida, USA.
[14]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[15]
Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[16]
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[17]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.;Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[18]
Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.;Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
[19]
Georgia Institute of Technology, Atlanta, Georgia, USA.
[20]
Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.;Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.;Weill Cornell Medical College, New York, New York, USA.
[21]
Department of Medicine, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
[22]
医学主题词
人类(Humans);预后(Prognosis);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);干细胞移植(Stem Cell Transplantation);缓解诱导(Remission Induction);移植, 同种(Transplantation, Homologous);肿瘤, 残余(Neoplasm, Residual);造血干细胞移植(Hematopoietic Stem Cell Transplantation)
DOI
10.1002/ajh.26757
PMID
36251406
发布时间
2026-05-27
- 浏览3
American journal of hematology
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
